patent

September 27, 2019September 27, 2019

Innate Biologics Granted Patent for Modified Anti-inflammatory Bacterial Proteins

News

Innate Biologics has been granted a U.S. patent for its bacterial protein-based anti-inflammatory technology, the company announced in a press release. The technology is based off of bacterial E3 ubiquitin ... Read more

May 17, 2017May 17, 2017

New Patent Cover IL-23R Orally Stable Peptide Inhibitors Including Protagonist’s PTG-200 to Treat IBD

News

Protagonist Therapeutics has secured a patent covering orally stable peptide inhibitors of the interleukin-23 receptor (IL-23R), including its lead candidate drug PTG-200. The patent protects PTG-200’s formulation as well the use of this ... Read more

May 11, 2017

Zydus Wins Appeal in Shire’s Patent Case Over Generic Lialda for UC

News

Zydus Pharmaceuticals won a patent battle over Shire’s ulcerative colitis drug Lialda (mesalamine), with the U.S. Court of Appeals for the Federal Circuit ruling that Zydus’ proposed generic version of Lialda ... Read more

November 15, 2016November 15, 2016

US Patent Issued for Atlantic Healthcare’s Alicaforsen to Treat IBD Pouchitis

News

A U.S. patent has been issued to Atlantic Healthcare’s investigational drug alicaforsen for the treatment of inflammatory bowel disease (IBD). The patent (No. 9453221) extends the use of alicaforsen in IBD-related rectal stump inflammation and ... Read more

August 28, 2015August 28, 2015

RedHill Biopharma Issued Notice of Allowance for New Israeli Patent Covering RHB-104

News

Israel-based biopharmaceutical company RedHill Biopharma Ltd., announced it has been issued a Notice of Allowance by the Israeli Patent Office for a new patent (No. 207420 – “Methods and Compositions for ... Read more

February 16, 2015February 16, 2015

VG Life Sciences Secures Patent For Cell-Protective IBD Treatment

IBD News, News

VG Life Sciences (VGLS), a biotechnology company committed to developing therapies for infectious and autoimmune diseases, recently announced that the U.S. Patent and Trademark Office (USPTO) has issued the company a Patent No. 8906846 covering a ... Read more

July 1, 2014

Pluristem Receives Russian Patent For Placenta-Derived Cell Treatment For Inflammatory Bowel Disease

IBD News, News

The Israeli-based placenta cell therapies developer Pluristem Therapeutics was recently granted a patent for its study “Methods of Treating Inflammatory Colon Diseases” by Russia’s Federal Service for Intellectual Property, as announced by the ... Read more